沃森生物：联合多家专业机构设立10亿元产业基金，聚焦合成生物前沿赛道

Core Viewpoint - Watson Bio has announced the establishment of the Yunnan Chuangwo Biological Industry Investment Fund, with a target size of 1 billion yuan, where the company will contribute 450 million yuan, accounting for 45% of the fund [1] Group 1: Investment Fund Details - The fund is initiated in collaboration with Guotou Chuangyi Industrial Fund Management Co., Ltd. and other parties [1] - The core investment focus of the fund is on synthetic biology, biomanufacturing, and biotechnology-related industries [1] Group 2: Strategic Implications - The establishment of the fund allows the company to closely engage with high-quality targets in the relevant fields [1] - This initiative is expected to provide rare opportunities for direct collaboration with target enterprises, laying the foundation for future industrial synergy and strategic mergers and acquisitions [1]